These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [A role of activation of proinflammatory cytokines and production of autoimmune complexes in the pathogenesis of chronic heart failure in patients with postinfarct cardiac dysfunction]. Tepliakov AT; Debirov MM; Bolotskaia LA; Stepacheva TA; Rybal'chenko EV; Karaman NV Klin Med (Mosk); 2004; 82(8):15-20. PubMed ID: 15468717 [TBL] [Abstract][Full Text] [Related]
10. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915 [TBL] [Abstract][Full Text] [Related]
12. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978 [TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Tsukada B; Terasaki F; Shimomura H; Otsuka K; Otsuka K; Katashima T; Fujita S; Imanaka-Yoshida K; Yoshida T; Hiroe M; Kitaura Y Hum Pathol; 2009 Jul; 40(7):1015-22. PubMed ID: 19297005 [TBL] [Abstract][Full Text] [Related]
15. The role of intravenous immunoglobulin in the treatment of chronic heart failure. Aukrust P; Yndestad A; Ueland T; Damås JK; Frøland SS; Gullestad L Int J Cardiol; 2006 Sep; 112(1):40-5. PubMed ID: 16893578 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives. Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412 [TBL] [Abstract][Full Text] [Related]
17. [The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease]. Sazhina EIu; Kozlova IV; Rebrov AP; Al'tshuler MIu Klin Med (Mosk); 2006; 84(12):20-4. PubMed ID: 17294877 [TBL] [Abstract][Full Text] [Related]
18. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Celis R; Torre-Martinez G; Torre-Amione G Curr Opin Cardiol; 2008 May; 23(3):254-60. PubMed ID: 18382215 [TBL] [Abstract][Full Text] [Related]
19. Role of inflammatory cytokines and chemoattractants in the rat model of streptozotocin-induced diabetic heart failure. Drimal J; Knezl V; Navarova J; Nedelcevova J; Paulovicova E; Sotnikova R; Snirc V; Drimal D Endocr Regul; 2008 Sep; 42(4):129-35. PubMed ID: 18999900 [TBL] [Abstract][Full Text] [Related]